Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
•
Stem Cell Transplantation
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Answer from: at Academic Institution
All patients with Hgb SS and patients with Hgb SC who have had any significant complications, excluding chronic pain.
Sign in or Register to read more
22690
Related Questions
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
In light of the Haven 7 trial results, what considerations should be made regarding the monitoring and management of potential long-term adverse effects of emicizumab in infants?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
What experience have you had with familial clustering of polycythemia vera?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?